Experts Discuss Clinical Application of TRK Inhibitors and Tumor Agnostic NTRK Fusion Testing

In this online educational program learn how to optimize oncology patient care by leveraging tumor-agnostic NTRK fusion testing and TRK inhibitors. Review expert insights on the latest data with an on-demand Webcast and downloadable slides from the live CCO symposium in Chicago.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Bayer Healthcare Pharma